Bleeding, itching, and the daily toilet-visit dread halve within weeks of consistent fibre and a different relationship with the bowl Alonso-Coello et al. 2006; for the cases that don't yield, rubber band ligation clears most of the rest in one or two clinic visits, no anesthesia, back to work the same day Iyer et al. 2004. The trade-off is honest: this is a lifelong adjustment to how you eat and how you use the toilet, not a six-week course. And the single hardest line of the entry, for anyone over forty-five with new bleeding: do not assume it's piles until a clinician has looked.
Hemorrhoids are not a disease you contract — they're a part of your body that everyone has. Three small, blood-filled cushions sit just inside the anal canal and help seal it shut, the way a rubber gasket does Lohsiriwat 2012. They engorge when you're holding it in and decompress when you go. The cushions are normal. What goes wrong is the anchor: a small band of connective tissue that holds them in place. Years of bearing down on hard stool, plus long unsupported sitting on the bowl, fray that anchor; the cushions slide downward, get exposed to passing stool, and start bleeding, itching, and prolapsing out Sandler & Peery 2019.
The ones above a small line inside the canal are internal — they bleed but usually don't hurt, because the rectum has no pain nerves. The ones below the line are external — fewer in number, but when a clot forms inside one (a thrombosed external), the pain is sharp and immediate. Internal hemorrhoids are graded I to IV: I bleeds but stays put, II pokes out when you strain and slips back on its own, III you push back in by hand, IV won't go back at all ASCRS 2018. Most people who ever have a problem have grade I or II. Most never need anything more than a different way of using the toilet.
The driver chain is short and unflattering. Hard stools mean a long, hard push. The push spikes pressure in the cushions to 100–200 mmHg. Sitting on a phone for fifteen minutes hoping something happens does the same thing, slowly. Pregnancy adds the weight of the uterus pressing on pelvic veins and hormones that loosen the venous walls; nearly four in ten pregnant women develop hemorrhoids by the third trimester Poskus et al. 2014. Age fades the anchor on its own.
What actually works
Most of the cures advertised at a pharmacy are for the symptoms, not the cause. The cause is your stool and how you sit. The boring news is that fibre — actual fibre, not a sprinkle on yoghurt — is the most evidenced single thing you can do.
For the bleeding and prolapse that doesn't clear with fibre, the workhorse next step is rubber band ligation — a sixty-second clinic procedure where a small elastic ring is slipped around the base of the hemorrhoid and the tissue dies off over the next week. No anesthesia, walk-in walk-out. A meta-analysis of eighteen trials across eight different procedures ranked banding the best non-surgical option for grade I to III disease, almost as effective as full surgery but with a fraction of the recovery MacRae & McLeod 1995. Multi-year follow-up of long-term patients shows about eight in ten remain symptom-controlled, with around one in ten eventually progressing to an operation Iyer et al. 2004.
Excisional surgery — the operation people fear — is reserved for grade IV (the cushions are stuck out) and grade III that has failed banding. The cure rate is around 95%, and the trade is two to three weeks of substantial postoperative pain Shanmugam et al. 2005. Stapled and artery-ligation alternatives have their place but the major RCT comparison (HubBLe, n = 372) showed that banding does better than artery ligation on cost and on early pain, with artery ligation only winning at the recurrence margin at 12 months Brown et al. 2016.
The phlebotonic tablets prescribed across most of continental Europe — micronised diosmin and hesperidin — have a Cochrane review of 24 trials behind them showing real but modest benefit on bleeding and itching Perera et al. 2012. They're absent from US shelves not because the evidence has been refuted but because the FDA hasn't approved them for this use. A reasonable second-line if your doctor will prescribe them.
What ignoring it actually looks like
Most people who have this don't tell anyone. The average patient delays a doctor visit by months to years — first because they hope it's a one-off, then because they're embarrassed, then because they've forgotten what life felt like without it. The cost is not dramatic. It's small, daily, and it accumulates.
What people around you notice first: you stop wearing certain pants. You skip the long meeting bathroom break and shift in your chair instead. You're quieter on car trips of more than two hours. You went off cycling. Your partner notices that you spend longer in the bathroom than you used to and don't say what's going on. You decline plans during a flare without explaining. The condition becomes a small private architecture inside an otherwise normal week.
A thrombosed external pile is its own brief crisis: a sharp lump that arrives overnight and stays acutely painful for several days, the kind of pain that wakes you up shifting in bed and won't let you sit at all. Postpartum women get hit particularly hard with this in the first 48 hours after a difficult delivery. It is a sleep-stealing, day-eating few days that resolves either with a clinic excision in the 72-hour window or with about a fortnight of patience Greenspon et al. 2004.
What happens biologically over years: untreated grade I tends to creep toward grade II, grade II toward grade III. The cushions that bled occasionally now prolapse routinely. The five-minute clinic procedure that would have worked at grade I becomes a longer recovery at grade III. Chronic low-grade bleeding can drop your iron levels enough to show as fatigue and pale skin — anemia from a pile is not common, but it happens, and it's slow enough that you don't notice Lohsiriwat 2015.
The single highest-stakes failure, though, is age-related and worth saying clearly: if you're past forty-five and you have new rectal bleeding, you cannot assume it's hemorrhoids. Colorectal cancer bleeds the same way. The guidance from major referral bodies is unambiguous — any new lower-GI bleeding over age 50 (NICE lowered this to under-50 with co-symptoms) needs to be looked at, not self-diagnosed NICE 2021. The patient who knew it was just piles for two years is a real case-report population, and the missed window is the difference between an endoscopic resection and an operation.
What to actually do
The conservative substrate is what most people need and what most people skip. It is not a six-week course; it is a permanent change to how you eat and how you use the toilet. Done consistently, it prevents most flares and resolves most that happen.
For an active flare — itching, irritation, the burn after a bowel movement — add a short course of topical hydrocortisone 1% twice daily for up to a week, plus warm sitz baths (10 to 15 minutes, two or three times a day). Topical lidocaine 5% handles the acute pain. Do not stay on hydrocortisone past a week or two — chronic use thins the skin and creates a rebound itch that gets blamed on the original hemorrhoid Cocorullo et al. 2017.
If the bleeding has not improved after four to six weeks of consistent conservative care, or if you're prolapsing, see a colorectal specialist for banding. The procedure takes longer to explain than to do: a small ring is applied to the base of the hemorrhoid, you get a few hours of dull pressure-feeling, the tissue sloughs over a week with a few spots of blood, and you're done. Usually one to three sessions, treating one or two columns at a time ASCRS 2018.
For an acutely painful lump that appeared overnight — a thrombosed external hemorrhoid — the timing matters. Within 72 hours of onset, excision under local anesthesia in the clinic gives substantially faster pain relief and a lower chance of recurrence than waiting it out (pain resolution in 1 to 4 days versus around 24 days with conservative care) Greenspon et al. 2004. Past 72 hours, the clot is organising and time is the treatment — sitz baths, sitting on a soft surface, oral analgesics, and around 7 to 14 days of patience.
When not to self-treat
If you're on a blood thinner — warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel — say so before any procedure. Standard practice for rubber band ligation involves pausing or bridging anticoagulation, because delayed bleeding from a sloughed band site is the main complication ASCRS 2018. Sclerotherapy and infrared coagulation are gentler alternatives when stopping the blood thinner isn't safe.
If your immune system is suppressed — HIV, chemotherapy, daily prednisone, post-transplant — the rare-but-serious risk of pelvic infection after banding rises, and you want a colorectal surgeon making the call, not a primary-care office ACG 2014.
If you're pregnant, the procedural options shrink. Stick to fibre, water, sitz baths, and short courses of the gentler topicals; banding and surgery wait until after delivery unless the situation is emergent Quijano & Abalos 2005.
What most people get wrong
The pile cream doesn't fix it. Tubes of Preparation H, Anusol, and the rest are symptom-soothers. They calm the itch and slightly shrink the swelling for a few hours. They do not address the slid cushion or the underlying constipation, which is the whole problem Cocorullo et al. 2017. The marketing implies otherwise, and a lot of people use cream for years instead of changing the substrate.
Not all anal bleeding is hemorrhoids. This is the single most dangerous self-diagnosis in primary care. The list of things that bleed from the same neighbourhood includes anal fissure, inflammatory bowel disease, diverticular disease, polyps, and colorectal cancer. The age-50 rule above isn't paranoia — it's the published referral standard NICE 2021.
Hemorrhoids aren't an abnormality. Everyone has them. The condition is the symptomatic state. If an incidental colonoscopy mentioned hemorrhoids and you've never had a symptom, you don't need treatment Sandler & Peery 2019.
Cold seats and spicy food are not the cause. Cultural folklore, no evidence. Chilli can transiently irritate an existing flare but doesn't cause the underlying problem Lohsiriwat 2015.
Surgery is not around the corner. The marketing of hemorrhoid clinics implies you're on a path toward the operating room. The clinical reality is that well over 80% of patients never need a surgical procedure — fibre and banding handle the rest Garg & Singh 2017.
"It'll go away on its own" is half-true. Acute flares often do. The underlying tendency, with the same toilet habits unchanged, doesn't.
If you're pregnant, postpartum, or past fifty
Pregnancy and the first weeks after birth. Roughly four in ten pregnant women develop hemorrhoids by the third trimester, and a similar share — often newly — find themselves with them postpartum Poskus et al. 2014. The combination of uterine pressure on pelvic veins, progesterone loosening venous walls, and pregnancy-associated constipation is the perfect storm. Long pushing during delivery, plus a big baby, can produce a thrombosed external pile in the first 48 hours postpartum — a sharp lump that genuinely hurts.
The toolkit shrinks: fibre, fluid, sitz baths, topical lidocaine, short courses of hydrocortisone 1% (generally regarded as low-risk in pregnancy, but ask your obstetrician), and time. Stool softeners like docusate are routine postpartum. Banding and excisional surgery wait until after delivery unless the situation is emergent Quijano & Abalos 2005. The reassurance most postpartum women aren't given clearly enough: a large fraction of pregnancy-related hemorrhoids regress over the months after birth as pressure drops and motility normalises.
Older adults. Symptomatic prevalence peaks at 45 to 65 and stays elevated Johanson & Sonnenberg 1990. The connective-tissue anchor weakens with age; prolapse becomes more likely. Two practical wrinkles: first, more people in this band are on blood thinners, which changes the procedural choice (sclerotherapy or infrared coagulation over banding). Second — and this matters most — new bleeding past about forty-five gets a colonoscopy, full stop. Self-diagnosis is the trap here, and the trap is occasionally fatal NICE 2021.
For everyone else — the under-forty sedentary office worker is the modern young-adult presentation, driven by hours-on-end at a desk plus the bowl-as-reading-room habit. The substrate above works fine. The phone is the single biggest behaviour change.
Why "I tried it and it didn't work"
You took fibre without water. Psyllium pulls water into the stool; if there's not enough water, it just hardens the stool. Worse outcome than no fibre at all. Pale-yellow urine is the visible feedback.
You stopped when it worked. The single most common pattern. Symptoms remit in four to six weeks; people drop the fibre; six months later they're back. The frame is lifelong, not a course. Treat it like brushing your teeth, not like a course of antibiotics Garg & Singh 2017.
You kept the phone in the bathroom. A different fifteen minutes a day on the bowl undoes whatever fibre is doing. The phone is the new newspaper, and it is the modern proximate driver in healthy people who can't figure out why this keeps recurring.
You used hydrocortisone for months. Chronic topical steroid thins the perianal skin and produces a rebound itch that gets blamed on the original hemorrhoid. Short courses only — one week, maybe two for a stubborn flare, then stop.
You self-diagnosed past fifty. See above. The percentage of people walking around assuming new bleeding is "just piles" who turn out to have something serious is small but real, and the cost of being wrong is high NICE 2021.
You didn't tell the doctor the real picture. Embarrassment shortens the conversation. A doctor with the full picture — what the blood looks like, when it happens, what the lump feels like, whether it goes back in on its own — can sort the diagnosis in a minute. Without it, the visit is wasted.
What this costs and where to go
The conservative kit is cheap. Psyllium runs about $10 to $25 a month at supplement doses; generic and bulk are cheaper. Hydrocortisone 1% cream is OTC for under $15. Topical lidocaine 5% is OTC or a cheap prescription. A sitz-bath insert that sits on the toilet is $15 to $25 one-time; warm water is free. Total annual spend for a well-managed conservative case is under $300.
Office procedures live with a colorectal surgeon or a gastroenterologist who does them. Rubber band ligation in the US runs roughly $300 to $800 a session out-of-pocket before insurance; covered by most plans with a normal specialist copay. Usually one to three sessions ASCRS 2018. You walk in, you walk out, you can drive home, and you can usually work the next day. Mild dull pressure and some spotting for a few days is expected.
Excisional hemorrhoidectomy is hospital-billed at $5,000 to $15,000 in the US (insurance-covered), and asks for two to three weeks of substantial postoperative pain — not the kind you tough out without strong analgesics for the first week. Plan time off work accordingly: one to two weeks minimum, full activity recovery around six weeks. Stapled and Doppler-guided artery-ligation procedures sit in the same ballpark on cost Tjandra & Chan 2007 Brown et al. 2016.
If you're in continental Europe or much of Asia, ask your doctor about diosmin/hesperidin tablets (Daflon, Detralex, generic). Routine prescription there, off-list in the US and UK, modest but real benefit for bleeding and itching Perera et al. 2012.
What changes when you start
Week 1. The acute flare calms first. Sitz baths and a short course of topical hydrocortisone settle the itch and burn in days. If you had a thrombosed external pile that you got excised within 72 hours, the sharp pain is gone in 1 to 4 days instead of three weeks Greenspon et al. 2004.
Weeks 2 to 6. The bleeding tapers. The fibre is doing what fibre does — softer, bulkier, faster stools, less pressure on the cushions, less trauma. Half-rate reduction in bleeding is the meta-analytic finding by week six of consistent use Alonso-Coello et al. 2006. The check-the-paper-every-time habit fades because most checks come back clean.
Months 2 to 6. The grade I or II that was prolapsing or threatening to has retreated. You stop carrying the pad in your bag. The version of you that scouted bathrooms before walking into a new office stops bothering. The chair-shifting on the long meeting goes away. If banding was needed, this is the window where it lands — one or two sessions, no anesthesia, a few days of dull pressure, then the same downhill curve as fibre alone but faster Iyer et al. 2004.
Years out. The trade is honest and ongoing. Stop the fibre, go back to the phone, and recurrence is near-certain. Keep the substrate in place and the cushions, no longer being repeatedly traumatised, settle into a stable low-symptom state. Four out of five long-term banding patients still report durable relief at multi-year follow-up Iyer et al. 2004. The small permanent shift in how you eat and how you sit is the price; the body going back to being a non-event is what you get.
Adjacent topics
The same toilet-and-stool substrate underwrites several neighbouring conditions, and the same conservative kit helps all of them. If the entry above hit nerves, these are worth a look:
- Chronic constipation. The upstream driver. If your stools are routinely hard, fibre and fluid alone may not be enough — there are good motility tools.
- Anal fissure. A small tear at the back of the anal canal, often confused with a pile, with a much sharper pain after defecation. Different treatment (topical nifedipine, sometimes botulinum).
- Pruritus ani. Chronic perianal itch with many causes; not always a hemorrhoid problem even when it looks like one.
- Colorectal cancer screening. The reason new bleeding past about forty-five gets a colonoscopy. Worth knowing where your country's screening starts and what the test feels like.
- Pelvic-floor dysfunction. If the straining is the problem and fibre isn't fixing it, the muscles may be the issue, not the stool. Pelvic-floor physiotherapy is underused.
1. Substance + claimed effects
Hemorrhoids are vascular cushions in the anal canal: dense, blood-filled submucosal pads that, along with the internal sphincter, help seal the anus and discriminate gas from stool Lohsiriwat 2012. They are normal anatomy. The clinical entity called "hemorrhoidal disease" is what happens when these cushions become engorged, slide downward, lose their connective-tissue moorings, or rupture — producing bleeding, prolapse, itching, soiling, and pain Sandler & Peery 2019. Internal hemorrhoids arise above the dentate line (visceral innervation; typically painless even when bleeding), external arise below (somatic innervation; painful when thrombosed). Internal hemorrhoids are graded I–IV by prolapse behaviour (Goligher grading): I bleeds without prolapse; II prolapses with strain and self-reduces; III requires manual reduction; IV is irreducibly prolapsed ASCRS 2018.
This entry covers the symptomatic condition end-to-end: drivers (straining, constipation, prolonged sitting, pregnancy, heavy lifting, low-fiber diet); the symptom complex (bleeding, itching, prolapse, pain, soiling, recurrence); the conservative substrate that resolves most cases (fiber, fluid, toilet-habit change, topical measures); and the office and operating-room procedures (rubber band ligation, sclerotherapy, infrared coagulation, hemorrhoidopexy, excisional hemorrhoidectomy, transanal hemorrhoidal dearterialization) when conservative care fails. Companion topics handled in their own entries: chronic constipation, anal fissure, pruritus ani, and colorectal-cancer screening — referenced here only as differentials and forward-pointers.
2. Evidence by addressing question
Mechanism
Anatomy. The three main hemorrhoidal cushions sit at the left lateral, right anterior, and right posterior positions in the canal. Each is a plexus of arterioles, venules, and arteriovenous communications cushioned by connective tissue (Treitz's muscle) anchoring them to the internal sphincter Lohsiriwat 2012. They engorge during continence and decompress during defecation. The classical "varicose vein" model is wrong — these are not varicosities of the portal system; portal hypertension causes rectal varices, a distinct entity Sandler & Peery 2019.
Pathophysiology. Two complementary mechanisms drive symptomatic disease. The sliding-anal-cushion theory (Thomson 1975) holds that repeated straining stretches and fragments Treitz's muscle, allowing the cushions to slide caudally; once distally displaced, mucosal vessels are exposed to passing stool, producing bleeding, and the cushions can prolapse Lohsiriwat 2012. The vascular hyperplasia theory adds that abnormal arteriovenous communications and reduced venous drainage cause persistent engorgement; histological studies confirm increased microvascular density in hemorrhoidal tissue Sneider & Maykel 2010. Elevated resting anal pressure has been documented in hemorrhoid patients, although whether it is cause or consequence remains debated.
Driver chain. Hard stools and prolonged Valsalva are the proximate insults. A typical defecatory strain raises intra-abdominal pressure to 100–200 mmHg; prolonged toilet sitting (often facilitated by reading material or, now, phones) holds the rectum and cushions in a dependent, unsupported position; both repeatedly traumatize the connective-tissue anchor Lohsiriwat 2012. Pregnancy adds direct pressure from the gravid uterus on pelvic venous return, plus progesterone-mediated venous laxity and pregnancy-associated constipation Poskus et al. 2014. Aging weakens the connective-tissue scaffold independently.
Evidence
Prevalence. Lifetime prevalence is high but estimates vary by source and definition. A US national-survey study put symptomatic prevalence at 4.4% in the general population and noted that prevalence peaks at age 45–65 Johanson & Sonnenberg 1990. A prospective screening-colonoscopy cohort of 976 Austrian patients found hemorrhoids on examination in 38.93%, with 44.7% of those symptomatic — i.e., roughly 1 in 6 of all examined adults Riss et al. 2012. A US screening-colonoscopy series of 1,074 patients reported similar order-of-magnitude figures and identified obesity, current pregnancy, and high-fiber diet as associated factors (the fiber association reflects reverse causation — fiber recommendation follows diagnosis) Peery et al. 2015.
Fiber. A Cochrane-style meta-analysis of 7 RCTs (n = 378) found fiber supplementation roughly halved the risk of persistent symptoms or non-improvement (RR 0.53, 95% CI 0.38–0.73) and produced a ~50% reduction in bleeding (RR 0.50, 95% CI 0.28–0.89) Alonso-Coello et al. 2006. Effect on prolapse, pain, and itching was smaller and statistically inconclusive. Onset was slow (weeks). The included trials were mostly with psyllium 7–20 g/day. Real-world doses needed to normalize stool typically run higher — psyllium 20–35 g/day is the practitioner range Garg & Singh 2017.
Rubber band ligation (RBL). A meta-analysis of 18 trials covering 8 modalities ranked RBL the best non-operative option, with efficacy approaching hemorrhoidectomy for grade I–III disease but with far less pain and faster return to activity MacRae & McLeod 1995. Long-term retrospective series report ~80% durable relief at multi-year follow-up, with ~10% of patients eventually requiring surgery Iyer et al. 2004. A Cochrane review found hemorrhoidectomy more effective for grade III–IV but with greater pain, longer recovery, and more complications; RBL remains the recommended first procedural step for grade I–III bleeding hemorrhoids Shanmugam et al. 2005.
Hemorrhoidal artery ligation vs RBL. The HubBLe trial (n = 372, UK multicentre RCT) compared Doppler-guided hemorrhoidal artery ligation (HAL) to RBL for grade II–III hemorrhoids. Recurrence at 12 months: HAL 30%, RBL 49% — but HAL caused more postoperative pain and was about 7× more expensive per patient. The trial concluded RBL should remain first-line, with HAL reserved for patients who fail repeated banding Brown et al. 2016.
Stapled hemorrhoidopexy. A systematic review of 25 RCTs comparing stapled hemorrhoidopexy with conventional hemorrhoidectomy found shorter operative time and less early pain but higher long-term recurrence and a higher rate of "skin-tag–like" prolapse Tjandra & Chan 2007. Rare but serious complications (rectovaginal fistula, pelvic sepsis, rectal stricture) shifted guideline opinion toward excisional hemorrhoidectomy for grade IV disease.
Phlebotonics. A Cochrane review of 24 trials (n > 2,000) of oral phlebotonic drugs (micronized purified flavonoid fraction, hesperidin/diosmin, hidrosmin, rutosides, calcium dobesilate) reported significant benefit on bleeding (RR 0.67), pruritus, and overall symptom score versus placebo, with a favourable safety profile Perera et al. 2012. The drugs are widely used in continental Europe and Asia; FDA has not approved them for hemorrhoids in the US, where they are largely absent. Effect size is modest and the trials are heterogeneous.
Topical agents. A systematic review found weak evidence for topical hydrocortisone (short-term symptom relief, not curative) and for topical nitroglycerin / nifedipine (which reduce internal-sphincter pressure and may help in coexisting fissure) Cocorullo et al. 2017. Topical anesthetics (lidocaine, pramoxine) help acute pain but provide no anatomic benefit. Witch hazel, zinc oxide, and other proprietary creams have minimal RCT data. The ASCRS guideline endorses topical measures only as adjuncts ASCRS 2018.
Protocol
Conservative substrate (everyone, first line). Fiber to 25–35 g/day (psyllium or methylcellulose), water to thirst (no fixed liter target; the urine-pale-yellow heuristic suffices), a fixed daily defecation window (typically post-breakfast to leverage the gastrocolic reflex), and the "no-Valsalva" rule: get up if a bowel movement isn't happening within ~3–5 minutes. Foot-elevation (squatty potty style) flattens the anorectal angle and reduces strain; small mechanistic studies support it but no high-quality RCTs exist ASCRS 2018. Sitz baths (10–15 min, warm water, 2–3×/day) provide symptomatic relief during flares and post-procedure recovery ACG 2014.
Topical short-course. Hydrocortisone 1% bd × 7 days for acute itching/inflammation; do not use chronically (skin atrophy). Lidocaine 5% for pain. Witch hazel pads as adjunct. Nifedipine 0.3% ointment if coexisting fissure Cocorullo et al. 2017.
Office procedures. RBL is the workhorse for grade I–III bleeding hemorrhoids; usually 1–3 sessions, each treating 1–2 columns at a time. Sclerotherapy and infrared coagulation are alternatives, useful in patients on anticoagulants for whom banding risks delayed bleeding ASCRS 2018. Performed in clinic, no anesthesia, return to work the same or next day.
Surgery. Excisional hemorrhoidectomy (Milligan-Morgan or Ferguson) for grade IV, grade III refractory to banding, large external components, or mixed internal-external disease. Higher cure rate (~95%), substantial postoperative pain for 2–3 weeks Shanmugam et al. 2005. Transanal hemorrhoidal dearterialization (THD/HAL-RAR) is an option for grade II–III who failed banding Brown et al. 2016.
Thrombosed external hemorrhoid. A separate acute entity. If presenting within 72 hours of onset with severe pain, surgical excision (not incision-and-drainage) under local anesthesia gives faster pain resolution and lower recurrence than conservative care (16% vs 24% recurrence; symptom relief in days vs ~24 days) Greenspon et al. 2004. After 72 hours, the clot is organizing and conservative management (sitz baths, analgesics, time) is appropriate; pain typically resolves over 7–14 days and the remaining skin tag may persist.
Contraindications
Topical hydrocortisone is contraindicated with active perianal infection. RBL is contraindicated on anticoagulation if the medication cannot be safely paused (relative; some operators do small-volume banding on uninterrupted DOACs but standard practice is bridging); sclerotherapy or infrared coagulation are alternatives ASCRS 2018. Immunocompromise (HIV, chemotherapy, high-dose steroids) raises the rare-but-serious risk of pelvic sepsis after banding and warrants surgical consultation ACG 2014. Pregnancy: conservative measures only (fiber, water, sitz baths, topical lidocaine, topical hydrocortisone short courses are generally regarded as safe); procedures are typically deferred until postpartum unless emergent Quijano & Abalos 2005.
Critically: anorectal bleeding in anyone over 45–50 (or with red-flag features: weight loss, change in bowel habit, family history of colorectal cancer, iron-deficiency anemia, dark or mixed-in blood) must not be attributed to hemorrhoids without colonoscopy. The mistake is age-old and life-threatening NICE 2021.
Misconceptions
"Pile cream cures it." Topicals ease symptoms; they do not address the prolapse, the slid cushion, or the underlying constipation. Chronic hydrocortisone use causes perianal skin atrophy and rebound itching Cocorullo et al. 2017.
"All anal bleeding is hemorrhoids." The most dangerous self-misdiagnosis in primary care. Colorectal cancer, fissure, inflammatory bowel disease, diverticular disease, and angiodysplasia all bleed per rectum. Up to ~10% of patients presenting with "hemorrhoidal bleeding" turn out to have another source on examination, rising with age. The rule: red flag in a patient ≥45–50 requires a look upstream NICE 2021.
"Hemorrhoids are abnormal — having them means something is wrong." The vascular cushions are normal anatomy; the disease is the symptomatic state. Asymptomatic findings on colonoscopy do not need treatment Sandler & Peery 2019.
"Sitting on cold surfaces / spicy food causes hemorrhoids." Cultural folklore with no evidence. Spicy food can transiently irritate but does not cause the underlying pathology Lohsiriwat 2015.
"Surgery is around the corner if you have hemorrhoids." The large majority — well over 80% in clinical series — never need an operation. The hierarchy goes conservative → office procedure → surgery, and most stop at step one or two Garg & Singh 2017.
Audience
Pregnancy and postpartum. A prospective cohort of 280 pregnant women showed cumulative incidence of hemorrhoids of 39% during pregnancy and 41% postpartum (often new, often resolving within months) Poskus et al. 2014. Conservative management dominates. Postpartum, prolonged labour and large infants raise the risk of thrombosed external hemorrhoids in the days after delivery. Sitz baths, topical anesthetics, stool softeners (docusate) and fiber are the standard postpartum kit Quijano & Abalos 2005.
Older adults. Symptomatic prevalence peaks at 45–65 and remains elevated thereafter Johanson & Sonnenberg 1990. Connective-tissue laxity makes prolapse more common; coexisting medications (anticoagulants, NSAIDs) complicate procedure planning. Always rule out cancer first NICE 2021.
Desk-bound workers. Risk factor cohort analysis points to obesity, sedentary work, and low fiber intake Peery et al. 2015. The toilet-as-reading-room habit (now toilet-as-phone-room) is the modern proximate driver in healthy young adults.
Alternatives
For the same underlying causal chain (constipation + Valsalva + dependent sitting), the same conservative substrate works whether the presentation is hemorrhoids, fissure, or pelvic-floor dysfunction. Where the diagnosis sits in any doubt — particularly with a posterior-midline tear suggesting fissure — refer to a colorectal specialist. Fiber supplements (psyllium > methylcellulose > wheat dextrin for bulk; ground flax for omega-3 bonus) are interchangeable for hemorrhoidal endpoints; pick what the patient will actually take. Probiotics, prebiotics, and fermented foods have insufficient evidence for hemorrhoidal endpoints specifically Alonso-Coello et al. 2006.
Failure modes
Fiber without water. Bulking agents without adequate fluid produce harder, drier stools — the opposite of the goal — and worsen straining.
Stopping the fiber when symptoms remit. Recurrence is the rule, not the exception, when toilet habits and stool consistency drift back. Lifelong adherence is the realistic frame, not a 6-week course Garg & Singh 2017.
Reading on the toilet. The single behavioural change most likely to convert a recurrence-prone patient into a stable one. The phone is the new newspaper.
Chronic hydrocortisone use. Perianal skin atrophy, rebound pruritus, fungal overgrowth — common iatrogenic loop.
Self-diagnosis past age 50. The patient who "knows it's just hemorrhoids" and never gets a colonoscopy is the case-report population for missed rectal cancer NICE 2021.
Practicalities
Psyllium (Metamucil, Konsyl, generic): roughly $10–25 / month at supplementation doses. Topical hydrocortisone 1%: OTC, $5–15. Lidocaine 5%: OTC or prescription, ~$10–30. RBL in the US: typically $300–800 per session out-of-pocket pre-insurance; covered by most insurance with a copay. Hemorrhoidectomy in the US: $5,000–15,000 hospital-billed depending on facility; insurance-covered. Recovery: RBL — same-day return to work, minor discomfort 1–3 days, expected small spotting; hemorrhoidectomy — 2–3 weeks of substantial pain, time off work typically 1–2 weeks, complete healing 6 weeks ASCRS 2018.
Stakes
Untreated symptomatic hemorrhoids tend to recur and progress: grade I that bled occasionally becomes grade II that prolapses, and over years sometimes grade III–IV requiring surgery instead of an office procedure. Chronic low-grade bleeding can cause iron-deficiency anemia, particularly in older patients with marginal reserves. Quality-of-life impact — pain during defecation, anxiety about toilet visits, soiling, social embarrassment — is documented but under-quantified; this is one of the most under-presented common conditions because patients delay seeking care Lohsiriwat 2015. The age-50+ failure mode (attributing cancer to hemorrhoids) is the high-stakes individual case.
Payoff
Fiber-led conservative care reduces bleeding by ~50% in 4–6 weeks of consistent use; itching and pain respond faster (often within 1–2 weeks) Alonso-Coello et al. 2006. RBL produces near-complete symptom resolution in 60–80% of grade I–III patients within 2–4 weeks of the final session Iyer et al. 2004. Acute thrombosed external excised within 72 hours: pain resolution in 1–4 days vs ~3 weeks with conservative care Greenspon et al. 2004. Long-term, the trade is real but unglamorous — a permanent change in toilet habits and stool consistency in exchange for stable, low-symptom-burden cushions over a lifetime.
Out of scope
Chronic constipation as a primary disorder (its own entry), anal fissure, pruritus ani, pelvic-floor dyssynergia, colorectal cancer screening, perianal Crohn's disease, perianal abscess and fistula, condyloma. All are differentials a careful workup must consider; none are this entry's substance.
3. The credibility range
Optimist case
Hemorrhoidal disease is one of the better-characterized common conditions. Anatomy is settled, pathophysiology is plausible and multi-mechanism, and the management hierarchy — fiber → topical → office procedure → surgery — is endorsed by every major society (ASCRS, ACG, ESCP) with broadly concordant recommendations ASCRS 2018 ACG 2014. Fiber has Cochrane-style meta-analytic support Alonso-Coello et al. 2006. Rubber band ligation has decades of multi-trial data and 80%+ long-term success Iyer et al. 2004. Excisional surgery is curative. Real-world outcomes match trial outcomes; specialist clinics see most patients managed without surgery. For an extremely common, embarrassing condition, the toolkit is unusually mature and the success rate is high if the patient engages.
Skeptic case
The evidence base looks thinner under inspection. The fiber meta-analysis is built on 7 small heterogeneous trials of 378 patients with varied endpoints, varied fiber doses, and varied follow-up; the effect on the symptoms that matter most to patients (prolapse, pain) is statistically uncertain Alonso-Coello et al. 2006. Much of the popular toolkit (witch hazel, zinc oxide, sitz baths) has minimal RCT support — usage is custom, not evidence. The "hemorrhoid" label is loose: prevalence ranges from 4.4% to 38.9% depending on whether the criterion is symptoms or any examination finding Johanson & Sonnenberg 1990 Riss et al. 2012, and many self-diagnosed "hemorrhoid" symptoms are something else (fissure, pruritus ani, polyps, neoplasia) Sandler & Peery 2019. The classical anatomic model has been refined repeatedly and there are still open questions about why some cushions become symptomatic and others stay quiet over decades. Surgical outcome data is mostly from specialist centers and may not generalize to community practice. The natural history without treatment is poorly characterized — a meaningful fraction of bleeding probably resolves spontaneously, complicating the interpretation of intervention trials.
Author's call
This is a real condition with effective, low-risk treatments at the conservative end and effective, well-characterized procedures at the next step up. The right framing for the reader is not "miracle cure or surgery" but "lifelong stool-and-toilet hygiene that, done consistently, prevents most cases and resolves most flares; office procedure for the recurrences that don't yield; surgery for the small grade III–IV residual." The single high-leverage editorial move is to refuse the cream-bottle framing the OTC industry has trained patients into and reground the entry in the unglamorous behavioural substrate. The second is to refuse to let "it's just hemorrhoids" remain the answer for an over-50 first-time bleeder. Evidence is meta-analytic-grade for fiber and RBL (evidence 4), confidently above 3 but not at the multi-RCT consensus tier required for 5. Field controversy is genuinely low (1) — disagreements concern procedural choice at the margin, not first principles.
4. Stakeholder + incentive map
OTC pharma. Hemorrhoid cream is a multi-hundred-million-dollar global category (Preparation H, Anusol, generics). Marketing strongly favours topical-as-treatment framing and product-as-solution narrative; the unglamorous behavioural advice (fiber, toilet habits) is invisible in advertising because it doesn't sell tubes. This creates persistent under-engagement with the actual driver.
Colorectal surgery / proctology. Both office procedures (banding) and operations are bread-and-butter for colorectal surgeons. Reimbursement structure favours intervention. Most specialists self-report conservative-first practice, but the systemic gradient leans toward earlier escalation.
Primary care. Underdiagnoses (patient embarrassment, brief visits, exam not performed), overattributes other bleeding to hemorrhoids (the cancer trap), under-prescribes fiber dose (5–10 g feels like a suggestion; 25–35 g is the actual target).
Patients and online communities. Reddit r/hemorrhoid, r/AskDocs, and similar forums show two recurring patterns: (a) patients who delayed care for months or years before realising the condition was both common and treatable, and (b) patients passing along folk remedies (apple cider vinegar, garlic, coconut oil) with no evidence base. The community signal is mostly that the condition is more disabling and more isolating than the medical literature reflects, and that primary-care interactions often disappoint.
Continental-European phlebotonic market. Diosmin/hesperidin (Daflon, Detralex) is widely prescribed in France, Italy, eastern Europe, parts of Asia; absent from the US guideline. The Cochrane review supports modest benefit Perera et al. 2012; the US/UK guideline silence reflects mainly that the drugs are not FDA-approved for hemorrhoids and not that the evidence has been refuted.
5. Population variability
Pregnant and postpartum women. Highest-incidence subgroup; third-trimester and immediate postpartum window is the peak. Often resolves over months without intervention. Treatment menu shrinks to conservative + a narrow topical set Poskus et al. 2014 Quijano & Abalos 2005.
Age 45–65. Highest sustained symptomatic prevalence in non-pregnant adults Johanson & Sonnenberg 1990. Connective-tissue degradation, decades of accumulated straining, and slower bowel transit all contribute.
Sedentary office workers and long-haul drivers. Prolonged sitting plus low fiber plus phone-on-toilet behaviour produces the modern young-adult presentation. Reversible by behavioural change in most.
Anticoagulated patients. Higher bleeding risk overall; RBL choice is constrained; sclerotherapy and IRC become preferred office procedures ASCRS 2018.
Constipation-dominant IBS and chronic constipation. Treat the underlying motility problem; otherwise hemorrhoidal recurrence is near-certain ACG 2014.
Genetic / connective-tissue. Family history is reported but the genetic architecture is poorly mapped; presumed polygenic plus environmental.
Athletes and lifters. Frequent Valsalva (heavy compound lifts, Olympic lifting) is plausibly contributory; clinical evidence is anecdotal. Bracing technique and breath strategy may modify risk.
6. Knowledge gaps
The natural history of asymptomatic hemorrhoids — how often they remit, how often they progress — is not well characterized; without it, intervention trials have a noisy comparator. The optimal fiber dose, type, and titration schedule is empirically anchored but not rigorously established; the gap between trial doses (7–20 g) and practice doses (25–35 g) reflects extrapolation, not data. Diosmin/hesperidin's true effect size, mechanism, and place in the US guideline is unresolved despite decades of European use Perera et al. 2012. The contribution of phone-on-toilet behaviour to modern incidence is hypothesized in clinical commentary but not formally studied. Long-term recurrence after rubber-band ligation (beyond 5 years) is sparsely tracked; some "recurrences" may be new hemorrhoids in untreated columns. And the foundational question — why some patients with identical risk factors develop symptomatic disease and others don't — has no satisfactory mechanistic answer.
Scope vs brief. The brief named bleeding, itching, pain, and recurrence as the consequences of interest, plus fiber, fluid, toilet habits, topical measures, and banding as the management levers. Article covers all of them end-to-end. The brief also named "procedures such as banding," which I read as a synecdoche; the article briefly covers excisional hemorrhoidectomy, stapled hemorrhoidopexy, transanal hemorrhoidal dearterialization, sclerotherapy, and infrared coagulation as well — banding is the workhorse but readers warranting referral need the wider menu. No silent narrowing.
Hard scoping calls.
- Colorectal cancer red flag is in scope. The "new bleeding past 45 needs a colonoscopy" line appears in stakes, contraindications, misconceptions, audience, and failure-modes. Repeated deliberately. The single most common life-threatening failure mode for self-managed hemorrhoid sufferers is misattribution of cancer bleeding; a once-only mention in passing felt under-weighted. Out-of-scope section flags screening as a future link.
- Diosmin/hesperidin (phlebotonics) is in scope but hedged. The Cochrane review supports modest benefit; the drugs are absent from US shelves but routine in Europe and Asia. The catalogue serves an international readership, so mentioning it (with the regional asymmetry called out) seemed right. ASCRS/ACG silence reflects FDA approval status, not refutation.
- Thrombosed external is treated as a sub-topic, not its own entry. It's a distinct acute presentation with a different protocol (the 72-hour excision window), but it's anatomically and behaviourally tied to the same substance. Splitting it would force a reader with a sudden painful lump to navigate to a separate page; I'd rather they find both treatments here.
Rating difficulties.
- Applicability scored 4, not 5. Lifetime prevalence is genuinely high (the 38.9% colonoscopy-based figure from Riss et al. 2012 would push to 5) but symptomatic prevalence at any given time is closer to 5% (Johanson & Sonnenberg 1990). The know-the-red-flag awareness audience is broader than the current-symptom audience, which is why this lands at 4 rather than 3 — closer to the smoking/screening framing in the spec than to a strict current-incidence count.
- Sleep and mood both scored 1. Both are small, real effects centred on acute flares (thrombosed external sleep loss, chronic embarrassment-related mood). Scoring 0 would be honest if we were grading only chronic stable disease; scoring 1 captures the flare population and the QOL data. The pitches lean on the flare framing to keep the friend-test bar.
- Evidence scored 4, not 5. Multi-trial meta-analyses exist for fibre and procedural ranking, plus aligned society guidelines — but the fibre meta is 7 small trials of 378 patients, which doesn't clear the 2+ large RCTs bar the spec sets for 5. Held the line.
Dream narrative tier. Overall score lands around 25 — well below the 40+ obligatory threshold. I wrote one anyway because the relief lever (a small private architecture of avoidance that goes away) maps unusually well to this topic; the dek and tagline lean on it lightly. If a reviewer reads the dek as too vivid for an under-40 entry, the safer fallback is to cut the "small private architecture" cadence and lead with the symptoms directly. I think the warmer version reads truer to the felt reality.
Separate-entry candidates surfaced during the write.
- Chronic constipation as an entry of its own. The driver upstream of hemorrhoids, fissures, and several other anorectal conditions. Warrants its own scoring (likely higher applicability, similar evidence base).
- Anal fissure. Frequently confused with hemorrhoids, different management (nifedipine, botulinum), and its own quality-of-life burden.
- Colorectal cancer screening. Tangential here but the natural future link for the "new bleeding past 45" thread.
- Pelvic-floor dysfunction / dyssynergic defecation. Underserved and increasingly recognised. The right home for the squat-stool and breath-strategy material that this entry only touches.
Future links. Once chronic-constipation, anal-fissure, colorectal-cancer-screening, and pelvic-floor-dysfunction exist, wire related here.
Editorial line I refused. The "five-step program to cure hemorrhoids forever" framing the marketing world has trained patients into. The honest frame is lifelong adjustment to stool and toilet habits, plus an effective procedure when needed — said plainly in the highlights and the failure-modes section.
Hemorrhoids
Psyllium ~$10–25/month, OTC topicals $5–30; rubber-band ligation is insurance-covered with a copay. Excisional hemorrhoidectomy is expensive but rarely needed. Trivial average cost for the conservative-led pathway most patients follow.
Ongoing fiber adherence (25–35 g/day) plus toilet-habit change (no phone, time-limited sit, fixed daily window) is a real but mild lifestyle shift. Lifelong adherence is the realistic frame — recurrence is the rule when the substrate drifts.
Cochrane-style meta-analysis supports fiber for hemorrhoid bleeding (Alonso-Coello et al. 2006); multi-trial evidence and guideline consensus (ASCRS 2018, ACG 2014) support rubber band ligation as first-line procedural management; HubBLe RCT clarifies HAL vs RBL placement (Brown et al. 2016). Strong evidence base; not yet the multi-large-RCT tier reserved for 5.
Conservative care (fiber 25–35 g/day, toilet-habit change, short-course topicals) plus banding when needed produces clear day-to-day functional improvement — bleeding halves within weeks (Alonso-Coello et al. 2006); itching and pain typically resolve faster. Rubber band ligation yields 60–80% durable symptom resolution at multi-year follow-up (Iyer et al. 2004). Real felt change for a condition that drives chronic toilet-visit dread.
A thrombosed external hemorrhoid produces severe pain for several days that interferes with sleep; postpartum hemorrhoids are notorious for the same. Outside acute flares, sleep impact is minimal. Trivial-to-minor effect overall.
Symptomatic hemorrhoids carry documented quality-of-life burden — chronic embarrassment, soiling, anxiety around defecation, social withdrawal — that resolves when the condition is treated (Lohsiriwat 2015). Effect is small but real, not the entry's headline.